Alfa Chemistry Releases Chemical Fluorophores for Bioanalysis, Environmental Monitoring, Clinical Diagnosis and Fluorescence Staining

Earlier this month, the management of Alfa Chemistry announced the launch of varieties of chemical fluorophores for researchers worldwide. Those newly released fluorophores, including BODIPY fluorophores, cyanine fluorophores, rhodamine fluorophores, and fluorescein fluorophores, can be widely used for bioanalysis, environmental monitoring, clinical diagnosis, fluorescence staining, as well as other application scenarios.

C. elegans Lysis/DNA Extraction Kits Available at Creative Biogene

Creative Biogene recently developed the C. elegans lysis/DNA extraction kits (CDC-k108) are now available to worldwide clients and partners.

Obtaining High-yield and Bioactive B. subtilis Bioproducts with Creative Biogene’s Cultivation Support

Creative Biogene announced the release of Bacillus subtilis cultivation service using flexible fermentation and cultivation strategies to help customers in obtaining high-yield and bioactive B. subtilis bioproducts.

MOBILION EXPANDS APPLICATIONS FOR MOBIE AND HIGHLIGHTS NEW RESEARCH AT ASMS 2022

MOBILion Systems Inc. delivers technical presentations and unveils new applications areas for its HRIM instrument, MOBIE, at ASMS 2022.

mdgroup appoints LaQuinta Jernigan as Chief Operating Officer

mdgroup appoints LaQuinta Jernigan as Chief Operating Officer Executive leadership appointment to drive seamless client experiences in patient- servicing and digitally enabled clinical trials

Andaman7 argues case for greater patient mediated research at HIMSS European Health Conference 2022

Medical Wellness Market report projects revenue to surpass US$ 4.3 Tn and CAGR would be 14.1% by 2031-end

As per Persistence Market Research’s latest industry analysis, the global medical wellness market was valued at over US$ 1 Tn in 2020, and is expected to exhibit a CAGR of 14.1% over the forecast period (2021-2031).

Terumo Pharmaceutical Solutions offers pre-fillable syringe solutions for demanding low dose applications such as ophthalmic

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has launched a pre-fillable polymer syringe for low dose applications such as ophthalmic drugs.

mdgroup recognised as one of the UK's fastest-growing private companies

mdgroup recognised as one of the UK's fastest-growing private companies 9 June 2022 - Bracknell, UK: mdgroup has been shortlisted as one of the UK's fastest-growing private companies in the inaugural Sunday Times 100 ranking.

SOPHiA GENETICS Provides an Update on its DEEP-Lung-IV Multimodal Clinical Study at ASCO 2022

Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancer

Optibrium expands UK head office with new facilities on Cambridge Innovation Park

CAMBRIDGE, UK, 08 June 2022: Optibrium™, a developer of software for drug discovery, today announced the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth and ongoing recruitment efforts to support the continued success and development of the company's innovative technology focused on improving the efficiency and productivity of the drug discovery process.

Medcura Appoints Surgical Medical Device Leader Jim Buck as New CEO

Medcura, Inc., a commercial-stage life science and medical device company, has appointed James (Jim) Buck as Chief Executive Officer (CEO). A globally connected leader, Buck has been serving as Director at Medcura since 2018 and now fully steps into the CEO role with more than 25 years of highly relevant career experiences.

Lyniate Names Scott Galbari President

Integrated DNA Technologies, Beckman Coulter Life Sciences Ink Distribution Deal

Diurnal to present research into new treatments of Congenital Adrenal Hyperplasia (CAH) at ENDO 2022

Diurnal Group plc (AIM: DNL), will be presenting research findings on the treatment and management of congenital adrenal hyperplasia (CAH) at this year’s American Endocrine Society meeting, ENDO 2022, which will be taking place between 11-14 June 2022 in Atlanta, USA.

Abzena Selects IPS for Turnkey Delivery of New CGMP Facility in North Carolina

IPS to provide full design, construction management and CQV services for Abzena's new monoclonal antibody (mAb) facility in Sanford, North Carolina.

Absolute Antibody Expands Prometheus™ Antibody Humanization Service to Include Non-Murine Origin Species

MediKarma Selects 1upHealth as its Interoperability Partner to Help Patients Acquire Their Medical Records from Hospital EMRs

Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the SEQuoia Express Stranded RNA Library Prep Kit. The kit provides biopharmaceutical and research scientists with an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive transcriptome profiling. The SEQuoia Express Stranded RNA Library Prep Kit offers a cost-effective and automation-friendly solution to the current challenges in library generation. The kit enables researchers to construct robust libraries that capture mRNA and long noncoding RNA (>200 bp) transcripts for differential gene expression analysis and novel transcript discovery. Bio-Rad™ also provides a complementary and customized bioinformatics solution to streamline the full next-generation sequencing (NGS) workflow, from library preparation to data analysis.

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value Goch, Germany (June 7th 2022) – DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, has facilities in 9 countries, employing around 450 people globally.